Incidence of hypertension and its risk factors in rural Kerala, India: A community-based cohort study

Public Health

Volumn 126, Issue 1, 2012, Pages 25-32

  Sathish, T ^a   Kannan, S ^a   Sarma, P S ^a   Razum, O ^b   Thankappan, K R ^a  

^a SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

^b BIELEFELD UNIVERSITY   (Germany)

Author keywords

Cohort study; Hypertension; Incidence; India; Risk factors

Indexed keywords

ANTIHYPERTENSIVE AGENT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

BIOCHEMISTRY; COHORT ANALYSIS; CONFIDENCE INTERVAL; EPIDEMIOLOGY; HEALTH CARE; HYPERTENSION; OBESITY; RISK FACTOR; RURAL AREA; SMOKING;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ARTICLE; ATTRIBUTABLE RISK; AWARENESS; BLOOD PRESSURE MEASUREMENT; BODY MASS; CENTRAL OBESITY; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CONTROL; EDUCATIONAL STATUS; FEMALE; FOOD INTAKE; FRUIT; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INCIDENCE; INDIA; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL ACTIVITY; PHYSICAL EXAMINATION; PROSPECTIVE STUDY; RISK FACTOR; RURAL POPULATION; SEX DIFFERENCE; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; VEGETABLE; WAIST CIRCUMFERENCE;

ADOLESCENT; ADULT; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INCIDENCE; INDIA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RESIDENCE CHARACTERISTICS; RISK FACTORS; RURAL POPULATION; YOUNG ADULT;

INDIA; KERALA;

EID: 84155164274     PISSN: 00333506     EISSN: 14765616     Source Type: Journal    
DOI: 10.1016/j.puhe.2011.11.002     Document Type: Article

References (49)

1. Ezzati M., Lopez A.D., Rodgers A., Vander Hoorn S., Murray C.J. Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet 2002, 360:1347-1360.
2. Kearney P.M., Whelton M., Reynolds K., Muntner P., Whelton P.K., He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005, 365:217-223.
3. Reddy K.S., Shah B., Varghese C., Ramadoss A. Responding to the threat of chronic diseases in India. Lancet 2005, 366:1744-1749.
4. Gupta R., Joshi P., Mohan V., Reddy K.S., Yusuf S. Epidemiology and causation of coronary heart disease and stroke in India. Heart 2008, 94:16-26.
5. Office of the Registrar General of India Provisional population totals: Kerala. census 2011, Available at:, (last accessed 09.04.11). http://censusindia.gov.in/2011-prov-results/data_files/kerala/Final_Kerala_Paper_1_Pdf.pdf.
6. State Planning Board Government of Kerala. Human development report 2005, Available at:, (last accessed 09.04.11). http://planningcommission.nic.in/plans/stateplan/sdr_pdf/shdr_kerala05.pdf.
7. World Health Organization World health statistics 2008, Available at:, (last accessed 09.04.11). http://www.who.int/whosis/whostat/EN_WHS08_Full.pdf.
8. Peters D.H., Rao K.S., Fryatt R. Lumping and splitting: the health policy agenda in India. Health Policy Plan 2003, 18:249-260.
9. Singh R.B., Fedacko J., Pella D., Macejova Z., Ghosh S., de Amit K., et al. Prevalence and risk factors for prehypertension and hypertension in five Indian cities. Acta Cardiol 2011, 66:29-37. Five City Study Group.
10. National Institute of Medical Statistics and Indian Council of Medical Research, GovernmEnt of India. Integrated disease surveillance Project: non-communicable disease risk factors survey. Phase 1 states of India: 2007-08. Available at: (last accessed 09.04.11). http://icmr.nic.in/final/IDSP-NCD%2520Reports/Phase-1%2520States%2520of%2520India.pdf.
11. Vijayakumar G., Arun R., Kutty V.R. High prevalence of type 2 diabetes mellitus and other metabolic disorders in rural Central Kerala. J Assoc Physicians India 2009, 57:563-567.
12. Thankappan K.R., Shah B., Mathur P., Sarma P.S., Srinivas G., Mini G.K., et al. Risk factor profile for chronic non-communicable diseases: results of a community-based study in Kerala, India. Indian J Med Res 2010, 131:53-63.
13. Gupta R. Trends in hypertension epidemiology in India. J Hum Hypertens 2004, 18:73-78.
14. Gopinath N., Chadha S.L., Shekhawat S., Tandon R.A. 3-year follow-up of hypertension in Delhi. Bull World Health Organ 1994, 72:715-720.
15. Gopinath N., Chadha S.L., Shekhawat S., Tandon R.A. 5-year follow-up study of hypertension in a rural community. Indian Heart J 1995, 47:129. [abstract].
16. Chronic Diseases and Health Promotion, World Health Organization. STEPwise approach to surveillance (STEPS). Available at: (last accessed 09.04.11). http://www.who.int/ncd_surveillance/steps/riskfactor/en/index.html.
17. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 1969, 6:24-27.
18. Allain C.C., Poon L.S., Chan C.S.G., Richmond W., Fu P.C. Enzymatic determination of total serum cholesterol. Clin Chem 1974, 20:470-475.
19. Fossati P., Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 1982, 28:2077-2080.
20. Guidelines Subcommittee 1999 world health Organization-International Society of hypertension guidelines for the management of hypertension. J Hypertens 1999, 17:151-183.
21. World Health Organization: Diet, nutrition and the prevention of chronic diseases: report of a joint WHO/FAO expert consultation. Available at: (last accessed 09.04.11). http://whqlibdoc.who.int/trs/who_trs_916.pdf.
22. WHO Expert Consultation Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004, 363:157-163.
23. Snehalatha C., Viswanathan V., Ramachandran A. Cutoff values for normal anthropometric variables in asian Indian adults. Diabetes Care 2003, 26:1380-1384.
24. World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. Available at: (last accessed 09.04.11). http://www.who.int/diabetes/publications/Definition%2520and%2520diagnosis%2520of%2520diabetes_new.pdf.
25. Expert Panel on Detection Evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the national cholesterol education Program (NCEP) expert Panel on Detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment Panel III). JAMA 2001, 285:2486-2497.
26. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
27. Prevalence, awareness, treatment and control of hypertension among the elderly in Bangladesh and India: a multicentre study. Bull World Health Organ 2001, 79:490-500. Hypertension Study Group.
28. Zhang J., Yu K.F. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 1998, 280:1690-1691.
29. Hennekens C.H., Buring J.E. Epidemiology in medicine 1987, Lippincott-Raven, Philadelphia.
30. Sun Z., Zheng L., Detrano R., Zhang X., Xu C., Li J., et al. Incidence and predictors of hypertension among rural Chinese adults: results from Liaoning province. Ann Fam Med 2010, 8:19-24.
31. Moreira L.B., Fuchs S.C., Wiehe M., Gus M., Moraes R.S., Fuchs F.D. Incidence of hypertension in Porto Alegre, Brazil: a population-based study. J Hum Hypertens 2008, 22:48-50.
32. Vasan R.S., Larson M.G., Leip E.P., Kannel W.B., Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001, 358:1682-1686.
33. Halimi J.M., Giraudeau B., Vol S., Cacès E., Nivet H., Tichet J. The risk of hypertension in men: direct and indirect effects of chronic smoking. J Hypertens 2002, 20:187-193.
34. Niskanen L., Laaksonen D.E., Nyyssönen K., Punnonen K., Valkonen V.P., Fuentes R., et al. Inflammation, abdominal obesity, and smoking as predictors of hypertension. Hypertension 2004, 44:859-865.
35. Wang W., Lee E.T., Fabsitz R.R., Devereux R., Best L., Welty T.K., et al. A longitudinal study of hypertension risk factors and their relation to cardiovascular disease: The Strong Heart Study. Hypertension 2006, 47:403-409.
36. Williamson D.F., Madans J., Anda R.F., Kleinman J.C., Giovino G.A., Byers T. Smoking cessation and severity of weight gain in a national cohort. N Engl J Med 1991, 324:739-745.
37. Huang Z., Willett W.C., Manson J.E., Rosner B., Stampfer M.J., Speizer F.E., et al. Body weight, weight change, and risk for hypertension in women. Ann Intern Med 1998, 128:81-88.
38. Julius S., Nesbitt S.D., Egan B.M., Weber M.A., Michelson E.L., Kaciroti N., et al. Trial of Preventing Hypertension (TROPHY) Study Investigators. feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med 2006, 354:1685-1697.
39. Appel L.J., Champagne C.M., Harsha D.W., Cooper L.S., Obarzanek E., Elmer P.J., et al. Writing group of the PREMIER Collaborative Research Group. effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA 2003, 289:2083-2093.
40. Gus M., Fuchs S.C., Moreira L.B., Moraes R.S., Wiehe M., Silva A.F., et al. Association between different measurements of obesity and the incidence of hypertension. Am J Hypertens 2004, 17:50-53.
41. Aekplakorn W., Kosulwat V., Suriyawongpaisal P. Obesity indices and cardiovascular risk factors in Thai adults. Int J Obes 2006, 30:1782-1790.
42. Banerji M.A., Faridi N., Atluri R., Chaiken R.L., Lebovitz H.E. Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. J Clin Endocrinol Metab 1999, 84:137-144.
43. Wajchenberg B.L. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000, 21:697-738.
44. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American heart Association/National heart, Lung, and blood Institute Scientific Statement. Circulation 2005, 112:2735-2752.
45. Expert Panel on the Identification Evaluation, and treatment of overweight in adults. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Am J Clin Nutr 1998, 68:899-917.
46. Addo J., Smeeth L., Leon D.A. Hypertension in sub-saharan Africa: a systematic review. Hypertension 2007, 50:1012-1018.
47. Kutty V.R. Historical analysis of the development of health care facilities in Kerala state, India. Health Policy Plan 2000, 15:103-109.
48. Egan B.M., Zhao Y., Axon R.N. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 2010, 303:2043-2050.
49. Department of Economics and Statistics, Government of Kerala. Annual vital statistics report 2008. Available at: (last accessed 09.04.11). http://www.cr.lsgkerala.gov.in/Docs/AnnualVitalStatisticalReport_2008.pdf.